Endoscopic Ultrasound Appearance of Pancreatic Serotonin-Staining Neuroendocrine Neoplasms: A Case Series Abstract #1639

Introduction: The pancreatic localization of serotonin-staining neuroendocrine neoplasms (serotoninomas) is extremely rare. Less than 350 cases have been reported in the world literature.
Aim(s): To describe a small series of 8 pancreatic serotoninomas in order to analyze the endoscopic ultrasound (EUS) appearance of this rare type of pancreatic neuroendocrine neoplasm (pNEN).
Materials and methods: Between 2010 and 2016, all consecutive patients with histologically proven pancreatic serotoninoma who had undergone EUS were enrolled
Conference: 14th Annual ENETS conference (2017)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: dr Sara Massironi
Keywords: pNEN

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1288 Vitamin D Deficiency as a Risk Factor in Pancreatic Neuroendocrine Neoplasms: Report from a Series at a Single Institute
Introduction: Vitamin D deficiency (VitDdef) is hypothesized to represent a risk factor in several neoplasms. To date, vitamin D levels have not been previously evaluated in patients with pancreatic neuroendocrine neoplasms (pNENs).
Conference: 13th Annual ENETS conference (2016)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: dr Sara Massironi
#1241 Health-Related Quality of Life in Patients after Diagnosis of Nonfunctioning Asymptomatic Pancreatic Neuroendocrine Neoplasms (PNEN) <= 2 cm
Introduction: Pancreatic neuroendocrine neoplasms (pNEN) <=2 cm can be treated conservatively.
Conference: 12th Annual ENETS Conference (2015)
Category: ...none of the below
Presenting Author: Angela Maurizi
Keywords: pNEN, quality of life
#2138 Eterogeneity of Duodenal Neuroendocrine Tumors: A Multi-Centre Experience In Italy
Introduction: The optimal management of duodenal neuroendocrine neoplasms (dNENs) is unclear and endoscopic resection is increasingly performed instead of surgery.
Conference: 15th Annual ENETS conference (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: MD Roberta Elisa Rossi
#1823 Effects of Low-Doses Aspirin on Clinical Outcome and Disease Progression in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors: Results of a Multicentric Retrospective Study
Introduction: The chemopreventive effect of aspirin (ASA) have been observed in the setting of colorectal cancer. The impact of aspirin use on clinical outcome of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP NEN) has not been evaluated yet
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: dr Sara Massironi
Keywords: NEN, ASA
#1863 Outcome of Surgical Resection after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) for Pancreatic Neuroendocrine Neoplasms: A Case-Matched Analysis
Introduction: Neoadjuvant Peptide receptor radionuclide therapy (NPRRT) can be an option for advanced pancreatic neuroendocrine neoplasms (PNEN) before surgery. Is not clear if NPRRT increases postoperative morbidity
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: Francesca Muffatti